Evidence map›Paper›PMID 27194756›Full record

ArticleJournal of virology2016

Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.

Cecile Rouleau, Arun T Pores Fernando, Justin H Hwang, Nathalie Faure, Tao Jiang, Elizabeth A White, Thomas M Roberts, Brian S Schaffhausen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Hippo Pathway and Viral Infections.Frontiers in microbiology · 2019
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cecile RouleauDepartment of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Arun T Pores FernandoDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Justin H HwangDepartment of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Nathalie FaureDepartment of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Tao JiangDepartment of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Elizabeth A WhiteDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Thomas M RobertsDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA thomas_roberts@dfci.harvard.edu brian.schaffhausen@tufts.edu.
Brian S SchaffhausenDepartment of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA thomas_roberts@dfci.harvard.edu brian.schaffhausen@tufts.edu.
Tufts University · USHarvard University · USDana-Farber Cancer Institute · US

Funding

VIRAL ONCOPROTEIN PERTURBATION OF RB/E2F PATHWAYP01CA050661 · NCI · DANA-FARBER CANCER INSTITUTE · PI HOWLEY, PETER M · 1989 to 2013
$35.8M
PROJECT 4: Interrogating PP2A Signaling in Human CancersP01CA203655 · NCI · DANA-FARBER CANCER INST · PI DECAPRIO, JAMES A. · 2017 to 2021
$8.0M
PRODUCTS OF THE TRANSFORMING GENES OF POLYOMAVIRUSR01CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1985 to 2015
$6.0M
MOLECULAR MECHANISMS OF POLYOMA INDUCED TRANSFORMATIONR01CA030002 · NCI · DANA-FARBER CANCER INSTITUTE · PI ROBERTS, THOMAS M · 1985 to 2014
$5.8M
MOLECULAR MECHANISMS OF POLYOMA-INDUCED TRANSFORMATIONR37CA030002 · NCI · DANA-FARBER CANCER INSTITUTE · PI ROBERTS, THOMAS M · 1993 to 1999
–
NCI NIH HHS P01 CA050661NCI NIH HHS P01 CA203655NCI NIH HHS R01 CA030002NCI NIH HHS R01 CA034722NCI NIH HHS R37 CA030002
6 · The paper itself

Abstract

unlabelledMurine polyomavirus has repeatedly provided insights into tumorigenesis, revealing key control mechanisms such as tyrosine phosphorylation and phosphoinositide 3-kinase (PI3K) signaling. We recently demonstrated that polyomavirus small T antigen (ST) binds YAP, a major effector of Hippo signaling, to regulate differentiation. Here we characterize YAP as a target of middle T antigen (MT) important for transformation. Through a surface including residues R103 and D182, wild-type MT binds to the YAP WW domains. Mutation of either R103 or D182 of MT abrogates YAP binding without affecting binding to other signaling molecules or the strength of PI3K or Ras signaling. Either genetic abrogation of YAP binding to MT or silencing of YAP via short hairpin RNA (shRNA) reduced MT transformation, suggesting that YAP makes a positive contribution to the transformed phenotype. MT targets YAP both by activating signaling pathways that affect it and by binding to it. MT signaling, whether from wild-type MT or the YAP-binding MT mutant, promoted YAP phosphorylation at S127 and S381/397 (YAP2/YAP1). Consistent with the known functions of these phosphorylated serines, MT signaling leads to the loss of YAP from the nucleus and degradation. Binding of YAP to MT brings it together with protein phosphatase 2A (PP2A), leading to the dephosphorylation of YAP in the MT complex. It also leads to the enrichment of YAP in membranes. Taken together, these results indicate that YAP promotes MT transformation via mechanisms that may depart from YAP's canonical oncogenic transcriptional activation functions. IMPORTANCE: The highly conserved Hippo/YAP pathway is important for tissue development and homeostasis. Increasingly, changes in this pathway are being associated with cancer. Middle T antigen (MT) is the primary polyomavirus oncogene responsible for tumor formation. In this study, we show that MT signaling promotes YAP phosphorylation, loss from the nucleus, and increased turnover. Notably, MT genetics demonstrate that YAP binding to MT is important for transformation. Because MT also binds PP2A, YAP bound to MT is dephosphorylated, stabilized, and localized to membranes. Taken together, these results indicate that YAP promotes MT transformation via mechanisms that depart from YAP's canonical oncogenic transcriptional activation functions.

Indexed as

Cell Transformation, ViralAnimalsAntigens, Polyomavirus TransformingBlotting, WesternCell Cycle ProteinsCell DifferentiationCells, CulturedFibroblastsFluorescent Antibody TechniqueHEK293 CellsHumansImmunoprecipitationMiceMutationNIH 3T3 CellsNuclear ProteinsAntigens, Polyomavirus TransformingCell Cycle ProteinsNuclear ProteinsPhosphatidylinositol 3-KinasesProtein Phosphatase 2RNA, MessengerTranscription FactorsYY1AP1 protein, human

Identifiers

PMID27194756
PMCPMC4984622
OpenAlexW2398962267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.